Serving hundreds of leading biopharmaceutical companies globally:

Generated: November 19, 2018

DrugPatentWatch Database Preview

Amag Pharma Usa Company Profile

« Back to Dashboard

What is the competitive landscape for AMAG PHARMA USA, and when can generic versions of AMAG PHARMA USA drugs launch?

AMAG PHARMA USA has one approved drug.

There are eight US patents protecting AMAG PHARMA USA drugs.

Summary for Amag Pharma Usa

US Patents:	8
Tradenames:	3
Ingredients:	1
NDAs:	1

Drugs and US Patents for Amag Pharma Usa

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amag Pharma Usa	MAKENA (AUTOINJECTOR)	hydroxyprogesterone caproate	SOLUTION;SUBCUTANEOUS	021945-004	Feb 14, 2018		RX	Yes	Yes	9,533,102	➤ Try a Free Trial	Y			➤ Try a Free Trial
Amag Pharma Usa	MAKENA PRESERVATIVE FREE	hydroxyprogesterone caproate	SOLUTION;INTRAMUSCULAR	021945-002	Feb 19, 2016	AP	RX	Yes	Yes		➤ Try a Free Trial				➤ Try a Free Trial
Amag Pharma Usa	MAKENA (AUTOINJECTOR)	hydroxyprogesterone caproate	SOLUTION;SUBCUTANEOUS	021945-004	Feb 14, 2018		RX	Yes	Yes	8,562,564	➤ Try a Free Trial	Y			➤ Try a Free Trial
Amag Pharma Usa	MAKENA (AUTOINJECTOR)	hydroxyprogesterone caproate	SOLUTION;SUBCUTANEOUS	021945-004	Feb 14, 2018		RX	Yes	Yes	8,021,335	➤ Try a Free Trial	Y			➤ Try a Free Trial
Amag Pharma Usa	MAKENA (AUTOINJECTOR)	hydroxyprogesterone caproate	SOLUTION;SUBCUTANEOUS	021945-004	Feb 14, 2018		RX	Yes	Yes	9,789,257	➤ Try a Free Trial	Y			➤ Try a Free Trial
Amag Pharma Usa	MAKENA (AUTOINJECTOR)	hydroxyprogesterone caproate	SOLUTION;SUBCUTANEOUS	021945-004	Feb 14, 2018		RX	Yes	Yes	RE44846	➤ Try a Free Trial	Y			➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for Amag Pharma Usa Drugs

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
European Patent Office	1104317	➤ Try a Free Trial
Japan	2016507305	➤ Try a Free Trial
World Intellectual Property Organization (WIPO)	0009186	➤ Try a Free Trial
European Patent Office	2731645	➤ Try a Free Trial
World Intellectual Property Organization (WIPO)	2006079064	➤ Try a Free Trial
World Intellectual Property Organization (WIPO)	2014124464	➤ Try a Free Trial
Country	Document Number	Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck

Colorcon

Chubb

Teva

Accenture

Medtronic

Harvard Business School

Baxter

Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.